The reaction of alpha-synuclein with tyrosinase: possible implications for Parkinson disease. (Q46663033)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18390556%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

title

The reaction of alpha-synuclein with tyrosinase: possible implications for Parkinson disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18390556%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

1 reference

1 reference

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18390556%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Isabella Tessari

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18390556%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Francesco Valle

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18390556%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

6

Stefano Mammi

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18390556%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Elisabetta Bergantino

series ordinal

5

object named as

Elisabetta Bergantino

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18390556%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

4

Bruno Samorì

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18390556%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

2

Marco Bisaglia

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18390556%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

language of work or name

English

0 references

publication date

4 April 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18390556%20AND%20SRC:MED&resulttype=core&format=json

Journal of Biological Chemistry

5 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18390556%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

volume

283

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18390556%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

issue

24

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18390556%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

page(s)

16808-16817

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18390556%20AND%20SRC:MED&resulttype=core&format=json

Genetics of Parkinson's disease and parkinsonism

5 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M709014200

Parkinson's disease: from causes to mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M709014200

Kinetic and structural analysis of the early oxidation products of dopamine: analysis of the interactions with alpha-synuclein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M709014200

Dopamine covalently modifies and functionally inactivates parkin

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M709014200

Dopamine oxidation alters mitochondrial respiration and induces permeability transition in brain mitochondria: implications for Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M709014200

Dopamine-dependent neurotoxicity of alpha-synuclein: a mechanism for selective neurodegeneration in Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M709014200

The synucleins: a family of proteins involved in synaptic function, plasticity, neurodegeneration and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M709014200

NACP, a protein implicated in Alzheimer's disease and learning, is natively unfolded

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M709014200

Stabilization of alpha-synuclein secondary structure upon binding to synthetic membranes

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M709014200

Effect of mutant alpha-synuclein on dopamine homeostasis in a new human mesencephalic cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M709014200

Dopamine synthesis, uptake, metabolism, and receptors: relevance to gene therapy of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M709014200

Neuromelanin biosynthesis is driven by excess cytosolic catecholamines not accumulated by synaptic vesicles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M709014200

Neuromelanin of the substantia nigra: a neuronal black hole with protective and toxic characteristics

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M709014200

Neuromelanin in human dopamine neurons: Comparison with peripheral melanins and relevance to Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M709014200

A proposed dual role of neuromelanin in the pathogenesis of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M709014200

Occurrence and distribution of 5-S-cysteinyl derivatives of dopamine, dopa and dopac in the brains of eight mammalian species

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M709014200

Neuromelanin synthesis in rat and human substantia nigra

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M709014200

Tyrosinase mRNA is expressed in human substantia nigra

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M709014200

New evidence for presence of tyrosinase in substantia nigra, forebrain and midbrain

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M709014200

Tyrosinase exacerbates dopamine toxicity but is not genetically associated with Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M709014200

WSXM: a software for scanning probe microscopy and a tool for nanotechnology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M709014200

A topological model of the interaction between alpha-synuclein and sodium dodecyl sulfate micelles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M709014200

Effects of Parkinson's disease-linked mutations on the structure of lipid-associated alpha-synuclein

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M709014200

Acceleration of oligomerization, not fibrillization, is a shared property of both alpha-synuclein mutations linked to early-onset Parkinson's disease: implications for pathogenesis and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M709014200

Does oxidative stress participate in nerve cell death in Parkinson's disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M709014200

Oxidative dimer formation is the critical rate-limiting step for Parkinson's disease alpha-synuclein fibrillogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M709014200

Characterization of products from the reactions of N-acetyldopamine quinone with N-acetylhistidine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M709014200

A broken alpha -helix in folded alpha -Synuclein

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M709014200

A structural and functional role for 11-mer repeats in alpha-synuclein and other exchangeable lipid binding proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M709014200

Structure of membrane-bound alpha-synuclein studied by site-directed spin labeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M709014200

Structure and dynamics of micelle-bound human alpha-synuclein

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M709014200

Impaired degradation of mutant alpha-synuclein by chaperone-mediated autophagy

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M709014200

Are amyloid diseases caused by protein aggregates that mimic bacterial pore-forming toxins?

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M709014200

Methionine oxidation, alpha-synuclein and Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M709014200

α-Synuclein facilitates the toxicity of oxidized catechol metabolites: Implications for selective neurodegeneration in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M709014200

21 January 2018

Identifiers

DOI

10.1074/JBC.M709014200

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18390556%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

1 reference